GSK chief to retire

Amy Schofield 17 March 2016

GSK CEO Sir Andrew Witty is to retire from the company in March 2017.

Sir Andrew has indicated to the board his intention to retire from the company next year after a decade at the helm. The board is now on the hunt for a successor and is looking to fill the role from either internal or external candidates. 

Sir Philip Hampton, Chairman, said: “We will now start a formal process to appoint his successor, whilst also ensuring the group remains focussed on execution of its strategy to drive growth and performance.”

Sir Andrew said: “GSK is a very special company with an inspiring mission and many dedicated people. By next year, I will have been CEO for nearly 10 years and I believe this will be the right time for a new leader to take over.”

Novartis' pharma chief, David Epstein, is rumoured to be a possible choice. Meanwhile, speaking on Sky News, investor Neil Woodford said: "I have a strong preference for an external candidate."



Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.